Skip to main content

Aortic Infection: Pathophysiology, Bacteriology, and Management

  • Chapter
  • First Online:
Diseases of the Aorta

Abstract

Primary aortic infections are a lethal disease process, and acquired aortic graft infections are a dreaded complication of vascular surgery. Fortunately, both are quite rare. Review of the literature should be done carefully since aortitis, infected or mycotic aortic aneurysm, and aortic graft infection are distinct clinical entities. Management of these infections is based on patient factors such as pre-existing conditions, anatomic location of the infection, and need for reconstruction as well as the bacteriology of the infection. Current endovascular options may offer the ability to stabilize the patient until definitive treatment or be sufficient to treat existing infection depending on both the patient and type of infection.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ewart JM, Burke ML, Bunt TJ. Spontaneous abdominal aortic infections. Essentials of diagnosis and management. Am Surg. 1983;49(1):37–50.

    CAS  PubMed  Google Scholar 

  2. Clagett GP, Vascular infection. In: Greenfield LJ, Mulholland MW, editors. Surgery: scientific principles and practice. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 1646–58.

    Google Scholar 

  3. Rojo-Leyva F, Ratliff NB, Cosgrove DM 3rd, Hoffman GS. Study of 52 patients with idiopathic aortitis from a cohort of 1,204 surgical cases. Arthritis Rheum. 2000;43(4):901–7.

    Article  CAS  PubMed  Google Scholar 

  4. Sekar N. Primary aortic infections and infected aneurysms. Ann Vasc Dis. 2010;3(1):24–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Fichelle JM, Tabet G, Cormier P, Farkas JC, Laurian C, Gigou F, et al. Infected infrarenal aortic aneurysms: when is in situ reconstruction safe? J Vasc Surg. 1993;17(4):635–45.

    Article  CAS  PubMed  Google Scholar 

  6. Lehner S, Wittgen C. Infections of the aorta: case report and review of treatment. Vascular. 2005;13(4):252–6.

    Article  PubMed  Google Scholar 

  7. Foote EA, Postier RG, Greenfield RA, Bronze MS. Infectious aortitis. Curr Treat Options Cardiovasc Med. 2005;7(2):89–97.

    Article  PubMed  Google Scholar 

  8. Virmani RBA. Non-atherosclerotic diseases of the aorta and miscellaneous disease of the main pulmonary arteries and veins. In: Silver MD, Gotlieb AI, Schoen FJ, editors. Cardiovascular pathology. 3rd ed. New York: Churchill Livingstone; 2001. p. 107–37.

    Google Scholar 

  9. Bayer ASSW. Endocarditis and intravascular infections. In: Mandell GL, Douglas RG, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 6th ed. Philadelphia: Elsevier/Churchill Livingstone; 2005. p. 857–902.

    Google Scholar 

  10. Gelabert HA, Quinones-Baldrich WJ. Mycotic aneurysm of the suprarenal aorta secondary to Streptococcus pneumoniae: an unusual pathogen. Ann Vasc Surg. 1991;5(6):529–32.

    Article  CAS  PubMed  Google Scholar 

  11. Gomes MN, Choyke PL, Wallace RB. Infected aortic-aneurysms - a changing entity. Ann Surg. 1992;215(5):435–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Yu SY, Hsieh HC, Ko PJ, Huang YK, Chu JJ, Lee CH. Surgical outcome for mycotic aortic and iliac anuerysm. World J Surg. 2011;35(7):1671–8.

    Article  PubMed  Google Scholar 

  13. Sorelius K, Mani K, Bjorck M, Sedivy P, Wahlgren CM, Taylor P, et al. Endovascular treatment of mycotic aortic aneurysms: a European multicenter study. Circulation. 2014;130(24):2136–42.

    Article  PubMed  CAS  Google Scholar 

  14. Brown SL, Busuttil RW, Baker JD, Machleder HI, Moore WS, Barker WF. Bacteriologic and surgical determinants of survival in patients with mycotic aneurysms. J Vasc Surg. 1984;1(4):541–7.

    Article  CAS  PubMed  Google Scholar 

  15. Ernst CB, Campbell HC Jr, Daugherty ME, Sachatello CR, Griffen WO Jr. Incidence and significance of intra-operative bacterial cultures during abdominal aortic aneurysmectomy. Ann Surg. 1977;185(6):626–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Ernst CB. Implications of bacterial culture from abdominal aortic aneurysms. Am J Surg. 1984;147(3):427–8.

    Article  CAS  PubMed  Google Scholar 

  17. Duncan JM, Cooley DA. Surgical considerations in aortitis. Part III: syphilitic and other forms of aortitis. Tex Heart Inst J. 1983;10(4):337–41.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Jackman JD Jr, Radolf JD. Cardiovascular syphilis. Am J Med. 1989;87(4):425–33.

    Article  PubMed  Google Scholar 

  19. Revest M, Decaux O, Cazalets C, Verohye JP, Jego P, Grosbois B. Thoracic infectious aortitis: microbiology, pathophysiology and treatment. Rev Med Interne. 2007;28(2):108–15.

    Article  CAS  PubMed  Google Scholar 

  20. Canaud L, Marzelle J, Bassinet L, Carrie AS, Desgranges P, Becquemin JP. Tuberculous aneurysms of the abdominal aorta. J Vasc Surg. 2008;48(4):1012–6.

    Article  PubMed  Google Scholar 

  21. Pathirana U, Kularatne S, Karunaratne S, Ranasinghe G, Fernando J. Ascending aortic aneurysm caused by Mycobacterium tuberculosis. BMC Res Notes. 2015;8:659.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Gornik HL, Creager MA. Aortitis. Circulation. 2008;117(23):3039–51.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Kim YW. Infected aneurysm: current management. Ann Vasc Dis. 2010;3(1):7–15.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Narang AT, Rathlev NK. Non-aneurysmal infectious aortitis: a case report. J Emerg Med. 2007;32(4):359–63.

    Article  PubMed  Google Scholar 

  25. Reddy DJWM. Infected aneurysms. In: Rutherford RB, editor. Vascular Surg. 6th ed. Philadelphia: Elsevier Saunders; 2005. p. 1581–96.

    Google Scholar 

  26. Kuestner LM, Reilly LM, Jicha DL, Ehrenfeld WK, Goldstone J, Stoney RJ. Secondary aortoenteric fistula: contemporary outcome with use of extraanatomic bypass and infected graft excision. J Vasc Surg. 1995;21(2):184–95. discussion 95-6.

    Article  CAS  PubMed  Google Scholar 

  27. Setacci C, de Donato G, Setacci F. Endografts for the treatment of aortic infection. Semin Vasc Surg. 2011;24(4):242–9.

    Article  PubMed  Google Scholar 

  28. Bennett DE. Primary mycotic aneurysms of the aorta. Report of case and review of the literature. Arch Surg. 1967;94(6):758–65.

    Article  CAS  PubMed  Google Scholar 

  29. Mundth ED, Darling RC, Alvarado RH, Buckley MJ, Linton RR, Austen WG. Surgical management of mycotic aneurysms and the complications of infection in vascular reconstructive surgery. Am J Surg. 1969;117(4):460–70.

    Article  CAS  PubMed  Google Scholar 

  30. Oz MC, Brener BJ, Buda JA, Todd G, Brenner RW, Goldenkranz RJ, et al. A ten-year experience with bacterial aortitis. J Vasc Surg. 1989;10(4):439–49.

    Article  CAS  PubMed  Google Scholar 

  31. Perler BA. The case for conservative management of infected prosthetic grafts. Adv Surg. 1996;29:17–32.

    CAS  PubMed  Google Scholar 

  32. Chen P, Lamki L, Raval B. Indium-111 leukocyte appearance of Salmonella mycotic aneurysm. Clin Nucl Med. 1994;19(7):646–8.

    Article  CAS  PubMed  Google Scholar 

  33. Modrall JG, Clagett GP. The role of imaging techniques in evaluating possible graft infections. Semin Vasc Surg. 1999;12(4):339–47.

    CAS  PubMed  Google Scholar 

  34. Olofsson PA, Auffermann W, Higgins CB, Rabahie GN, Tavares N, Stoney RJ. Diagnosis of prosthetic aortic graft infection by magnetic resonance imaging. J Vasc Surg. 1988;8(2):99–105.

    Article  CAS  PubMed  Google Scholar 

  35. Reeps C, Essler M, Pelisek J, Seidl S, Eckstein HH, Krause BJ. Increased 18F-fluorodeoxyglucose uptake in abdominal aortic aneurysms in positron emission/computed tomography is associated with inflammation, aortic wall instability, and acute symptoms. J Vasc Surg. 2008;48(2):417–23. discussion 24.

    Article  PubMed  Google Scholar 

  36. Muller BT, Wegener OR, Grabitz K, Pillny M, Thomas L, Sandmann W. Mycotic aneurysms of the thoracic and abdominal aorta and iliac arteries: Experience with anatomic and extra-anatomic repair in 33 cases. J Vasc Surg. 2001;33(1):106–13.

    Article  CAS  PubMed  Google Scholar 

  37. Ihaya A, Chiba Y, Kimura T, Morioka K, Uesaka T. Surgical outcome of infectious aneurysm of the abdominal aorta with or without SIRS. Cardiovasc Surg. 2001;9(5):436–40.

    Article  CAS  PubMed  Google Scholar 

  38. Moneta GL, Taylor LM, Yeager RA, Edwards JM, Nicoloff AD, McConnell DB, et al. Surgical treatment of infected aortic aneurysm. Am J Surg. 1998;175(5):396–9.

    Article  CAS  PubMed  Google Scholar 

  39. Oderich GS, Panneton JM, Bower TC, Cherry KJ, Rowland CM, Noel AA, et al. Infected aortic aneurysms: aggressive presentation, complicated early outcome, but durable results. J Vasc Surg. 2001;34(5):900–7.

    Article  CAS  PubMed  Google Scholar 

  40. Hsu RB, Chang CI, Wu IH, Lin FY. Selective medical treatment of infected aneurysms of the aorta in high risk patients. J Vasc Surg. 2009;49(1):66–70.

    Article  PubMed  Google Scholar 

  41. Kaufman JL, Smith R, Capel GC, Shah DM, Chang BB, Leather RP. Antibiotic therapy for arterial infection: lessons from the successful treatment of a mycotic femoral artery aneurysm without surgical reconstruction. Ann Vasc Surg. 1990;4(6):592–6.

    Article  CAS  PubMed  Google Scholar 

  42. Huber TS, Treatment for infected aortic grafts. In: Zelenock GB, editor. Mastery of vascular and endovascular surgery. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 2071–5.

    Google Scholar 

  43. Hsu RB, Chen RJ, Wang SS, Chu SH. Infected aortic aneurysms: clinical outcome and risk factor analysis. J Vasc Surg. 2004;40(1):30–5.

    Article  PubMed  Google Scholar 

  44. Lin CH, Hsu RB. Primary infected aortic aneurysm: clinical presentation, pathogen, and outcome. Acta Cardiol Sin. 2014;30(6):514–21.

    PubMed  PubMed Central  Google Scholar 

  45. Bandyk DF, Novotney ML, Johnson BL, Back MR, Roth SR. Use of rifampin-soaked gelatin-sealed polyester grafts for in situ treatment of primary aortic and vascular prosthetic infections. J Surg Res. 2001;95(1):44–9.

    Article  CAS  PubMed  Google Scholar 

  46. Batt M, Magne JL, Alric P, Muzj A, Ruotolo C, Ljungstrom KG, et al. In situ revascularization with silver-coated polyester grafts to treat aortic infection: early and midterm results. J Vasc Surg. 2003;38(5):983–9.

    Article  PubMed  Google Scholar 

  47. Hernandez-Richter T, Schardey HM, Wittmann F, Mayr S, Schmitt-Sody M, Blasenbreu S, et al. Rifampin and Triclosan but not silver is effective in preventing bacterial infection of vascular dacron graft material. Eur J Vasc Endovasc Surg. 2003;26(5):550–7.

    Article  CAS  PubMed  Google Scholar 

  48. Malassiney P, Goeau-Brissonniere O, Coggia M, Pechere JC. Rifampicin loading of vascular grafts. J Antimicrob Chemother. 1996;37(6):1121–9.

    Article  CAS  PubMed  Google Scholar 

  49. Lew W, Moore W. Antibiotic-impregnated grafts for aortic reconstruction. Semin Vasc Surg. 2011;24(4):211–9.

    Article  PubMed  Google Scholar 

  50. Oderich GS, Bower TC, Hofer J, Kalra M, Duncan AA, Wilson JW, et al. In situ rifampin-soaked grafts with omental coverage and antibiotic suppression are durable with low reinfection rates in patients with aortic graft enteric erosion or fistula. J Vasc Surg. 2011;53(1):99–107.

    Article  PubMed  Google Scholar 

  51. Weis-Muller BT, Rascanu C, Sagban A, Grabitz K, Godehardt E, Sandmann W. Single-center experience with open surgical treatment of 36 infected aneurysms of the thoracic, thoracoabdominal, and abdominal aorta. Ann Vasc Surg. 2011;25(8):1020–5.

    Article  PubMed  Google Scholar 

  52. Dubois M, Daenens K, Houthoofd S, Peetermans WE, Fourneau I. Treatment of mycotic aneurysms with involvement of the abdominal aorta: single-centre experience in 44 consecutive cases. Eur J Vasc Endovasc Surg. 2010;40(4):450–6.

    Article  CAS  PubMed  Google Scholar 

  53. Inoue T, Nishino T, Peng YF, Saga T. Successful one-stage operation of aortoesophageal fistula from thoracic aneurysm using a rifampicin-soaked synthetic graft. Interact Cardiovasc Thorac Surg. 2008;7(2):322–4.

    Article  PubMed  Google Scholar 

  54. Reilly LM, Stoney RJ, Goldstone J, Ehrenfeld WK. Improved management of aortic graft infection: the influence of operation sequence and staging. J Vasc Surg. 1987;5(3):421–31.

    Article  CAS  PubMed  Google Scholar 

  55. Seeger JM, Pretus HA, Welborn MB, Ozaki CK, Flynn TC, Huber TS. Long-term outcome after treatment of aortic graft infection with staged extra-anatomic bypass grafting and aortic graft removal. J Vasc Surg. 2000;32(3):451–9. discussion 60-1.

    Article  CAS  PubMed  Google Scholar 

  56. Chung J, Clagett GP. Neoaortoiliac System (NAIS) procedure for the treatment of the infected aortic graft. Semin Vasc Surg. 2011;24(4):220–6.

    Article  PubMed  Google Scholar 

  57. Santilli SM, Lee ES, Wernsing SE, Diedrich DA, Kuskowski MA, Shew RL. Superficial femoral popliteal vein: an anatomic study. J Vasc Surg. 2000;31(3):450–5.

    Article  CAS  PubMed  Google Scholar 

  58. Bernatchez J, Gauvin V, Gilbert N, Rheaume P. Long-term results of the Neoaortoiliac system procedure for aortic graft infections and mycotic aneurysms: a single-center experience. J Vasc Surg. 2016;64(5):1544.

    Article  Google Scholar 

  59. Szilagyi DE, Hemmer JA. Resection of aortic bifurcation and replacement with homologous graft for aneurysm. J Am Med Assoc. 1954;154(9):751–3.

    Article  CAS  PubMed  Google Scholar 

  60. Gournier JP, Adham M, Favre JP, Raba M, Bancel B, Lepetit JC, et al. Cryopreserved arterial homografts: preliminary study. Ann Vasc Surg. 1993;7(6):503–11.

    Article  CAS  PubMed  Google Scholar 

  61. Solanes N, Rigol M, Castella M, Khabiri E, Ramirez J, Segales J, et al. Cryopreservation alters antigenicity of allografts in a porcine model of transplant vasculopathy. Transplant Proc. 2004;36(10):3288–94.

    Article  CAS  PubMed  Google Scholar 

  62. Pasquinelli G, Pistillo MP, Ricci F, Buzzi M, Tazzari PL, Foroni L, et al. The “in situ” expression of human leukocyte antigen class I antigens is not altered by cryopreservation in human arterial allografts. Cell Tissue Bank. 2007;8(3):195–203.

    Article  CAS  PubMed  Google Scholar 

  63. Heo SH, Kim YW, Woo SY, Park YJ, Kim DK, Chung DR. Recent results of in situ abdominal aortic reconstruction with cryopreserved arterial allograft. Eur J Vasc Endovasc Surg. 2017;53(2):158–67.

    Article  PubMed  Google Scholar 

  64. Vogt PR, Brunner-La Rocca HP, Carrel T, von Segesser LK, Ruef C, Debatin J, et al. Cryopreserved arterial allografts in the treatment of major vascular infection: a comparison with conventional surgical techniques. J Thorac Cardiovasc Surg. 1998;116(6):965–72.

    Article  CAS  PubMed  Google Scholar 

  65. Vogt PR, Brunner-LaRocca HP, Lachat M, Ruef C, Turina MI. Technical details with the use of cryopreserved arterial allografts for aortic infection: influence on early and midterm mortality. J Vasc Surg. 2002;35(1):80–6.

    Article  PubMed  Google Scholar 

  66. Touma J, Cochennec F, Parisot J, Fialaire Legendre A, Becquemin JP, Desgranges P. In situ reconstruction in native and prosthetic aortic infections using cryopreserved arterial allografts. Eur J Vasc Endovasc Surg. 2014;48(3):292–9.

    Article  CAS  PubMed  Google Scholar 

  67. Leseche G, Castier Y, Petit MD, Bertrand P, Kitzis M, Mussot S, et al. Long-term results of cryopreserved arterial allograft reconstruction in infected prosthetic grafts and mycotic aneurysms of the abdominal aorta. J Vasc Surg. 2001;34(4):616–22.

    Article  CAS  PubMed  Google Scholar 

  68. Vogt PR, Vonsegesser LK, Goffin Y, Pasic M, Turina MI. Cryopreserved arterial homografts for in-situ reconstruction of mycotic-aneurysms and prosthetic graft infection. Eur J Cardiothorac Surg. 1995;9(9):502–6.

    Article  CAS  PubMed  Google Scholar 

  69. Harlander-Locke MP, Harmon LK, Lawrence PF, Oderich GS, McCready RA, Morasch MD, et al. The use of cryopreserved aortoiliac allograft for aortic reconstruction in the United States. J Vasc Surg. 2014;59(3):669–74.

    Article  PubMed  Google Scholar 

  70. Lopes RJ, Almeida J, Dias PJ, Pinho P, Maciel MJ. Infectious thoracic aortitis: a literature review. Clin Cardiol. 2009;32(9):488–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Kahlberg A, Melissano G, Tshomba Y, Leopardi M, Chiesa R. Strategies to treat thoracic aortitis and infected aortic grafts. J Cardiovasc Surg. 2015;56(2):269–80.

    CAS  Google Scholar 

  72. Mani K, Bjorck M, Lundkvist J, Wanhainen A. Improved long-term survival after abdominal aortic aneurysm repair. Circulation. 2009;120(3):201–11.

    Article  PubMed  Google Scholar 

  73. Dellinger RP. The surviving sepsis campaign: where have we been and where are we going? Cleve Clin J Med. 2015;82(4):237–44.

    Article  PubMed  Google Scholar 

  74. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580–637.

    Article  PubMed  Google Scholar 

  75. Maluso P, Olson J, Sarani B. Abdominal compartment hypertension and abdominal compartment syndrome. Crit Care Clin. 2016;32(2):213–22.

    Article  PubMed  Google Scholar 

  76. Balogh ZJ, Malbrain M. Resuscitation in intra-abdominal hypertension and abdominal compartment syndrome. Am Surg. 2011;77(Suppl 1):S31–3.

    PubMed  Google Scholar 

  77. Clough RE, Black SA, Lyons OT, Zayed HA, Bell RE, Carrell T, et al. Is endovascular repair of mycotic aortic aneurysms a durable treatment option? Eur J Vasc Endovasc Surg. 2009;37(4):407–12.

    Article  CAS  PubMed  Google Scholar 

  78. Seeger JM, Back MR, Albright JL, Carlton LM, Harward TR, Kubulis PS, et al. Influence of patient characteristics and treatment options on outcome of patients with prosthetic aortic graft infection. Ann Vasc Surg. 1999;13(4):413–20.

    Article  CAS  PubMed  Google Scholar 

  79. Lin CH, Hsu RB. Primary infected aortic aneurysm: clinical presentation, pathogen, and outcome. Acta Cardiologica Sinica. 2014;30(6):514–21.

    PubMed  PubMed Central  Google Scholar 

  80. Wilson WR, Bower TC, Creager MA, Amin-Hanjani S, O'Gara PT, Lockhart PB, et al. Vascular graft infections, mycotic aneurysms, and endovascular infections: a scientific statement from the American Heart Association. Circulation. 2016;134(20):e412–e60.

    Article  PubMed  Google Scholar 

  81. Seeger JM. Management of patients with prosthetic vascular graft infection. Am Surg. 2000;66(2):166–77.

    CAS  PubMed  Google Scholar 

  82. Vogel TR, Symons R, Flum DR. The incidence and factors associated with graft infection after aortic aneurysm repair. J Vasc Surg. 2008;47(2):264–9.

    Article  PubMed  Google Scholar 

  83. Bandyk DF, Berni GA, Thiele BL, Towne JB. Aortofemoral graft infection due to Staphylococcus epidermidis. Arch Surg. 1984;119(1):102–8.

    Article  CAS  PubMed  Google Scholar 

  84. Swain TW 3rd, Calligaro KD, Dougherty MD. Management of infected aortic prosthetic grafts. Vasc Endovasc Surg. 2004;38(1):75–82.

    Article  Google Scholar 

  85. Kieffer E, Bahnini A, Koskas F, Ruotolo C, Le Blevec D, Plissonnier D. In situ allograft replacement of infected infrarenal aortic prosthetic grafts: results in forty-three patients. J Vasc Surg. 1993;17(2):349–55. discussion 55-6.

    Article  CAS  PubMed  Google Scholar 

  86. Hayes PD, Nasim A, London NJ, Sayers RD, Barrie WW, Bell PR, et al. In situ replacement of infected aortic grafts with rifampicin-bonded prostheses: the Leicester experience (1992 to 1998). J Vasc Surg. 1999;30(1):92–8.

    Article  CAS  PubMed  Google Scholar 

  87. O’Connor S, Andrew P, Batt M, Becquemin JP. A systematic review and meta-analysis of treatments for aortic graft infection. J Vasc Surg. 2006;44(1):38–45.

    Article  PubMed  Google Scholar 

  88. Bandyk DF. Vascular surgical site infection: risk factors and preventive measures. Semin Vasc Surg. 2008;21(3):119–23.

    Article  PubMed  Google Scholar 

  89. Treska V, Certik B, Molacek J. Management of aortic graft infections - the present strategy and future perspectives. Bratisl Lek Listy. 2016;117(3):125–32.

    CAS  PubMed  Google Scholar 

  90. Szilagyi DE, Smith RF, Elliott JP, Vrandecic MP. Infection in arterial reconstruction with synthetic grafts. Ann Surg. 1972;176(3):321–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. Herscu G, Wilson SE. Prosthetic infection: lessons from treatment of the infected vascular graft. Surg Clin North Am. 2009;89(2):391–401. viii.

    Article  PubMed  Google Scholar 

  92. Goldstone J, Moore WS. Infection in vascular prostheses. Clinical manifestations and surgical management. Am J Surg. 1974;128(2):225–33.

    Article  CAS  PubMed  Google Scholar 

  93. Culver DH, Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG, et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System. Am J Med. 1991;91(3B):152S–7S.

    Article  CAS  PubMed  Google Scholar 

  94. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999;20(4):250–78. quiz 79-80.

    Article  CAS  PubMed  Google Scholar 

  95. Schurink GW, Peppelenbosch N, Mees B, Jacobs MJ. Diagnostic algorithms and treatment strategies in primary aortic and aortic graft infections. J Cardiovasc Surg. 2016;57(2):224–32.

    Google Scholar 

  96. Daenens K, Fourneau I, Nevelsteen A. Ten-year experience in autogenous reconstruction with the femoral vein in the treatment of aortofemoral prosthetic infection. Eur J Vasc Endovasc Surg. 2003;25(3):240–5.

    Article  CAS  PubMed  Google Scholar 

  97. Chambers ST. Diagnosis and management of staphylococcal infections of vascular grafts and stents. Intern Med J. 2005;35(Suppl 2):S72–8.

    Article  PubMed  Google Scholar 

  98. Hodgkiss-Harlow KD, Bandyk DF. Antibiotic therapy of aortic graft infection: treatment and prevention recommendations. Semin Vasc Surg. 2011;24(4):191–8.

    Article  PubMed  Google Scholar 

  99. Garot M, Delannoy PY, Meybeck A, Sarraz-Bournet B, d'Elia P, d'Escrivan T, et al. Intra-abdominal aortic graft infection: prognostic factors associated with in-hospital mortality. BMC Infect Dis. 2014;14:215.

    Article  PubMed  PubMed Central  Google Scholar 

  100. Qvarfordt PG, Reilly LM, Mark AS, Goldstone J, Wall SD, Ehrenfeld WK, et al. Computerized tomographic assessment of graft incorporation after aortic reconstruction. Am J Surg. 1985;150(2):227–31.

    Article  CAS  PubMed  Google Scholar 

  101. Valentine RJ. Diagnosis and management of aortic graft infection. Semin Vasc Surg. 2001;14(4):292–301.

    Article  CAS  PubMed  Google Scholar 

  102. Spartera C, Morettini G, Petrassi C, Marino G, Minuti U, Pavone P, et al. Role of magnetic resonance imaging in the evaluation of aortic graft healing, perigraft fluid collection, and graft infection. Eur J Vasc Surg. 1990;4(1):69–73.

    Article  CAS  PubMed  Google Scholar 

  103. Shahidi S, Eskil A, Lundof E, Klaerke A, Jensen BS. Detection of abdominal aortic graft infection: comparison of magnetic resonance imaging and indium-labeled white blood cell scanning. Ann Vasc Surg. 2007;21(5):586–92.

    Article  PubMed  Google Scholar 

  104. Spacek M, Belohlavek O, Votrubova J, Sebesta P, Stadler P. Diagnostics of “non-acute” vascular prosthesis infection using 18F-FDG PET/CT: our experience with 96 prostheses. Eur J Nucl Med Mol Imaging. 2009;36(5):850–8.

    Article  CAS  PubMed  Google Scholar 

  105. Lawrence PF, Dries DJ, Alazraki N, Albo D Jr. Indium 111-labeled leukocyte scanning for detection of prosthetic vascular graft infection. J Vasc Surg. 1985;2(1):165–73.

    CAS  PubMed  Google Scholar 

  106. Lyons OT, Baguneid M, Barwick TD, Bell RE, Foster N, Homer-Vanniasinkam S, et al. Diagnosis of aortic graft infection: a case definition by the Management of Aortic Graft Infection Collaboration (MAGIC). Eur J Vasc Endovasc Surg. 2016;52(6):758–63.

    Article  CAS  PubMed  Google Scholar 

  107. Ducasse E, Calisti A, Speziale F, Rizzo L, Misuraca M, Fiorani P. Aortoiliac stent graft infection: current problems and management. Ann Vasc Surg. 2004;18(5):521–6.

    Article  PubMed  Google Scholar 

  108. Laser A, Baker N, Rectenwald J, Eliason JL, Criado-Pallares E, Upchurch GR Jr. Graft infection after endovascular abdominal aortic aneurysm repair. J Vasc Surg. 2011;54(1):58–63.

    Article  PubMed  Google Scholar 

  109. Sharif MA, Lee B, Lau LL, Ellis PK, Collins AJ, Blair PH, et al. Prosthetic stent graft infection after endovascular abdominal aortic aneurysm repair. J Vasc Surg. 2007;46(3):442–8.

    Article  PubMed  Google Scholar 

  110. Ohta T, Hosaka M, Ishibashi H, Sugimoto I, Takeuchi N, Kazui H, et al. Treatment for aortic graft infection. Surg Today. 2001;31(1):18–26.

    Article  CAS  PubMed  Google Scholar 

  111. Hobbs SD, Kumar S, Gilling-Smith GL. Epidemiology and diagnosis of endograft infection. J Cardiovasc Surg. 2010;51(1):5–14.

    CAS  Google Scholar 

  112. Setacci C, De Donato G, Setacci F, Chisci E, Perulli A, Galzerano G, et al. Management of abdominal endograft infection. J Cardiovasc Surg. 2010;51(1):33–41.

    CAS  Google Scholar 

  113. May J. Complications of endovascular aortic repair. J Cardiovasc Surg. 2010;51(1):1–3.

    CAS  Google Scholar 

  114. Samson RH, Veith FJ, Janko GS, Gupta SK, Scher LA. A modified classification and approach to the management of infections involving peripheral arterial prosthetic grafts. J Vasc Surg. 1988;8(2):147–53.

    Article  CAS  PubMed  Google Scholar 

  115. Reilly L. Aortic graft infection: evolution in management. Cardiovasc Surg. 2002;10(4):372–7.

    Article  PubMed  Google Scholar 

  116. Brown KE, Heyer K, Rodriguez H, Eskandari MK, Pearce WH, Morasch MD. Arterial reconstruction with cryopreserved human allografts in the setting of infection: a single-center experience with midterm follow-up. J Vasc Surg. 2009;49(3):660–6.

    Article  PubMed  Google Scholar 

  117. Saleem BR, Meerwaldt R, Tielliu IF, Verhoeven EL, van den Dungen JJ, Zeebregts CJ. Conservative treatment of vascular prosthetic graft infection is associated with high mortality. Am J Surg. 2010;200(1):47–52.

    Article  PubMed  Google Scholar 

  118. Armstrong PA, Back MR, Bandyk DF, Johnson BL, Shames ML. Selective application of sartorius muscle flaps and aggressive staged surgical debridement can influence long-term outcomes of complex prosthetic graft infections. J Vasc Surg. 2007;46(1):71–8.

    Article  PubMed  Google Scholar 

  119. Siracuse JJ, Nandivada P, Giles KA, Hamdan AD, Wyers MC, Chaikof EL, et al. Prosthetic graft infections involving the femoral artery. J Vasc Surg. 2013;57(3):700–5.

    Article  PubMed  PubMed Central  Google Scholar 

  120. Lyons OT, Patel AS, Saha P, Clough RE, Price N, Taylor PR. A 14-year experience with aortic endograft infection: management and results. Eur J Vasc Endovasc Surg. 2013;46(3):306–13.

    Article  CAS  PubMed  Google Scholar 

  121. Smeds MR, Duncan AA, Harlander-Locke MP, Lawrence PF, Lyden S, Fatima J, et al. Treatment and outcomes of aortic endograft infection. J Vasc Surg. 2016;63(2):332–40.

    Article  PubMed  Google Scholar 

  122. Lawrence PF. Conservative treatment of aortic graft infection. Semin Vasc Surg. 2011;24(4):199–204.

    Article  PubMed  Google Scholar 

  123. Belair M, Soulez G, Oliva VL, Laperriere J, Gianfelice D, Blair JF, et al. Aortic graft infection: the value of percutaneous drainage. AJR Am J Roentgenol. 1998;171(1):119–24.

    Article  CAS  PubMed  Google Scholar 

  124. Morris GE, Friend PJ, Vassallo DJ, Farrington M, Leapman S, Quick CR. Antibiotic irrigation and conservative surgery for major aortic graft infection. J Vasc Surg. 1994;20(1):88–95.

    Article  CAS  PubMed  Google Scholar 

  125. Samoukovic G, Bernier PL, Lachapelle K. Successful treatment of infected ascending aortic prosthesis by omental wrapping without graft removal. Ann Thorac Surg. 2008;86(1):287–9.

    Article  PubMed  Google Scholar 

  126. Antoniou GA, Koutsias S, Antoniou SA, Georgiakakis A, Lazarides MK, Giannoukas AD. Outcome after endovascular stent graft repair of aortoenteric fistula: a systematic review. J Vasc Surg. 2009;49(3):782–9.

    Article  PubMed  Google Scholar 

  127. Xiromeritis K, Dalainas I, Stamatakos M, Filis K. Aortoenteric fistulae: present-day management. Int Surg. 2011;96(3):266–73.

    Article  PubMed  Google Scholar 

  128. Alonso M, Caeiro S, Cachaldora J, Segura R. Infected abdominal aortic aneurysm: in situ replacement with cryopreserved arterial homograft. J Cardiovasc Surg (Torino). 1997;38(4):371–5.

    CAS  Google Scholar 

  129. Bandyk DF, Novotney ML, Back MR, Johnson BL, Schmacht DC. Expanded application of in situ replacement for prosthetic graft infection. J Vasc Surg. 2001;34(3):411–9. discussion 9-20.

    Article  CAS  PubMed  Google Scholar 

  130. Vardanian AJ, Chau A, Quinones-Baldrich W, Lawrence PE. Arterial allograft allows in-line reconstruction of prosthetic graft infection with low recurrence rate and mortality. Am Surg. 2009;75(10):1000–3.

    PubMed  Google Scholar 

  131. Lehnert T, Gruber HP, Maeder N, Allenberg JR. Management of primary aortic graft infection by extra-anatomic bypass reconstruction. Eur J Vasc Surg. 1993;7(3):301–7.

    Article  CAS  PubMed  Google Scholar 

  132. Ali AT, Modrall JG, Hocking J, Valentine RJ, Spencer H, Eidt JF, et al. Long-term results of the treatment of aortic graft infection by in situ replacement with femoral popliteal vein grafts. J Vasc Surg. 2009;50(1):30–9.

    Article  PubMed  Google Scholar 

  133. Clagett GP, Valentine RJ, Hagino RT. Autogenous aortoiliac/femoral reconstruction from superficial femoral-popliteal veins: feasibility and durability. J Vasc Surg. 1997;25(2):255–66. discussion 67-70.

    Article  CAS  PubMed  Google Scholar 

  134. Yeager RA, Moneta GL, Taylor LM Jr, Harris EJ Jr, McConnell DB, Porter JM. Improving survival and limb salvage in patients with aortic graft infection. Am J Surg. 1990;159(5):466–9.

    Article  CAS  PubMed  Google Scholar 

  135. Yeager RA, Taylor LM Jr, Moneta GL, Edwards JM, Nicoloff AD, McConnell DB, et al. Improved results with conventional management of infrarenal aortic infection. J Vasc Surg. 1999;30(1):76–83.

    Article  CAS  PubMed  Google Scholar 

  136. Bunt TJ. Synthetic vascular graft infections. I. Graft infections. Surgery. 1983;93(6):733–46.

    CAS  PubMed  Google Scholar 

  137. Yashar JJ, Weyman AK, Burnard RJ, Yashar J. Survival and limb salvage in patients with infected arterial prostheses. Am J Surg. 1978;135(4):499–504.

    Article  CAS  PubMed  Google Scholar 

  138. Ricotta JJ, Faggioli GL, Stella A, Curl GR, Peer R, Upson J, et al. Total excision and extra-anatomic bypass for aortic graft infection. Am J Surg. 1991;162(2):145–9.

    Article  CAS  PubMed  Google Scholar 

  139. Sharp WJ, Hoballah JJ, Mohan CR, Kresowik TF, Martinasevic M, Chalmers RT, et al. The management of the infected aortic prosthesis: a current decade of experience. J Vasc Surg. 1994;19(5):844–50.

    Article  CAS  PubMed  Google Scholar 

  140. Noel AA, Gloviczki P, Cherry KJ Jr, Safi H, Goldstone J, Morasch MD, et al. Abdominal aortic reconstruction in infected fields: early results of the United States cryopreserved aortic allograft registry. J Vasc Surg. 2002;35(5):847–52.

    Article  PubMed  Google Scholar 

  141. Oderich GS, Bower TC, Cherry KJ Jr, Panneton JM, Sullivan TM, Noel AA, et al. Evolution from axillofemoral to in situ prosthetic reconstruction for the treatment of aortic graft infections at a single center. J Vasc Surg. 2006;43(6):1166–74.

    Article  PubMed  Google Scholar 

  142. Zhou W, Lin PH, Bush RL, Terramani TT, Matsuura JH, Cox M, et al. In situ reconstruction with cryopreserved arterial allografts for management of mycotic aneurysms or aortic prosthetic graft infections: a multi-institutional experience. Tex Heart Inst J. 2006;33(1):14–8.

    PubMed  PubMed Central  Google Scholar 

  143. Koskas F, Goeau-Brissonniere O, Nicolas MH, Bacourt F, Kieffer E. Arteries from human beings are less infectible by Staphylococcus aureus than polytetrafluoroethylene in an aortic dog model. J Vasc Surg. 1996;23(3):472–6.

    Article  CAS  PubMed  Google Scholar 

  144. Berger P, Van Herwaarden JA, Harkisoen S, De Vries JP, Ekkelenkamp M, Moll FL. Surgical treatment of infected aortic grafts. J Cardiovasc Surg. 2012;53(6):719–34.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wittgen, C.M., Sanford, J.L., Doan, M.K. (2019). Aortic Infection: Pathophysiology, Bacteriology, and Management. In: Dieter, R., Dieter Jr., R., Dieter III, R. (eds) Diseases of the Aorta . Springer, Cham. https://doi.org/10.1007/978-3-030-11322-3_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-11322-3_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-11321-6

  • Online ISBN: 978-3-030-11322-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics